These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25169642)

  • 21. Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study.
    Drueke B; Baetz J; Boecker M; Moeller O; Hiemke C; Gründer G; Gauggel S
    Psychopharmacology (Berl); 2009 Dec; 207(2):213-23. PubMed ID: 19756527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of short-term escitalopram treatment on neural activation during emotional processing.
    Maron E; Wall M; Norbury R; Godlewska B; Terbeck S; Cowen P; Matthews P; Nutt DJ
    J Psychopharmacol; 2016 Jan; 30(1):33-9. PubMed ID: 26645207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.
    Bhagwagar Z; Cowen PJ; Goodwin GM; Harmer CJ
    Am J Psychiatry; 2004 Jan; 161(1):166-8. PubMed ID: 14702268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined NK₁ antagonism and serotonin reuptake inhibition: effects on emotional processing in humans.
    Harmer CJ; Dawson GR; Dourish CT; Favaron E; Parsons E; Fiore M; Zucchetto M; Bifone A; Poggesi I; Fernandes S; Alexander RC; Goodwin GM
    J Psychopharmacol; 2013 May; 27(5):435-43. PubMed ID: 23407644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.
    Harmer CJ; Mackay CE; Reid CB; Cowen PJ; Goodwin GM
    Biol Psychiatry; 2006 May; 59(9):816-20. PubMed ID: 16460693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.
    Hirsh-Rokach B; Spectre G; Shai E; Lotan A; Ritter A; Al-Aieshy F; Malmström RE; Varon D; Alcalai R
    Pharmacotherapy; 2015 Feb; 35(2):140-7. PubMed ID: 25689244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of citalopram and escitalopram on fMRI response to affective stimuli in healthy volunteers selected by serotonin transporter genotype.
    Henry ME; Lauriat TL; Lowen SB; Churchill JH; Hodgkinson CA; Goldman D; Renshaw PF
    Psychiatry Res; 2013 Sep; 213(3):217-24. PubMed ID: 23845563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network.
    Ma Y; Li B; Wang C; Zhang W; Rao Y; Han S
    Br J Psychiatry; 2015 May; 206(5):385-92. PubMed ID: 25745133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
    Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
    EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects.
    Paul MA; Gray GW; Love RJ; Lange M
    Aviat Space Environ Med; 2007 Jul; 78(7):693-7. PubMed ID: 17679567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
    Nadeem HS; Attenburrow MJ; Cowen PJ
    Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of oxytocin on pupil response to naturalistic dynamic facial expressions.
    Burley DT; Daughters K
    Horm Behav; 2020 Sep; 125():104837. PubMed ID: 32750332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling.
    Sladky R; Spies M; Hoffmann A; Kranz G; Hummer A; Gryglewski G; Lanzenberger R; Windischberger C; Kasper S
    Neuroimage; 2015 Mar; 108():243-50. PubMed ID: 25536499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial.
    Zoons E; Tijssen MAJ; Dreissen YEM; Smit M; Booij J
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32521736
    [No Abstract]   [Full Text] [Related]  

  • 36. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.
    Godlewska BR; Norbury R; Selvaraj S; Cowen PJ; Harmer CJ
    Psychol Med; 2012 Dec; 42(12):2609-17. PubMed ID: 22716999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute pharmacologically induced shifts in serotonin availability abolish emotion-selective responses to negative face emotions in distinct brain networks.
    Grady CL; Siebner HR; Hornboll B; Macoveanu J; Paulson OB; Knudsen GM
    Eur Neuropsychopharmacol; 2013 May; 23(5):368-78. PubMed ID: 22739125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central serotonin modulates neural responses to virtual violent actions in emotion regulation networks.
    Wolf D; Klasen M; Eisner P; Zepf FD; Zvyagintsev M; Palomero-Gallagher N; Weber R; Eisert A; Mathiak K
    Brain Struct Funct; 2018 Sep; 223(7):3327-3345. PubMed ID: 29948188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease.
    Labuschagne I; Jones R; Callaghan J; Whitehead D; Dumas EM; Say MJ; Hart EP; Justo D; Coleman A; Dar Santos RC; Frost C; Craufurd D; Tabrizi SJ; Stout JC;
    Psychiatry Res; 2013 May; 207(1-2):118-26. PubMed ID: 23051887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.